Marc Lallemant, Research Associate in Immunology and Infectious Diseases
Immunology+Infectious Diseases Thailand
Dates of Research:
August 10, 2007 — May 31, 2012
The primary objective of this study is to assess the efficacy, safety and tolerance of a single dose of nevirapine given to women at onset of labor and to their infant 48 to 72 hours after birth, in addition to the current zidovudine regimen given in Thailand.